Inborn Gene or Chromosome Alterations - Medical Devices Pipeline Assessment, 2016

  • ID: 4027407
  • Report
  • 307 pages
  • GlobalData
1 of 4

FEATURED COMPANIES

  • 3D Signatures Inc
  • Da An Gene Co Ltd
  • Good Start Genetics Inc
  • KellBenx Inc
  • PreCyte, Inc.
  • Sheba Medical Center
  • MORE
Inborn Gene or Chromosome Alterations - Medical Devices Pipeline Assessment, 2016

Summary

The Medical Devices sector report, “Inborn Gene or Chromosome Alterations - Medical Devices Pipeline Assessment, 2016" provides an overview of Inborn Gene or Chromosome Alterations currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Inborn Gene or Chromosome Alterations pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by a team of industry experts.

Scope

- Extensive coverage of the Inborn Gene or Chromosome Alterations under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Inborn Gene or Chromosome Alterations and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons to buy

- The report enables you to:
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Inborn Gene or Chromosome Alterations under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date

- Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • 3D Signatures Inc
  • Da An Gene Co Ltd
  • Good Start Genetics Inc
  • KellBenx Inc
  • PreCyte, Inc.
  • Sheba Medical Center
  • MORE
1.1 List of Tables

1.2 List of Figures

2 Introduction

2.1 Inborn Gene or Chromosome Alterations Overview

3 Products under Development

3.1 Inborn Gene or Chromosome Alterations - Pipeline Products by Stage of Development

3.2 Inborn Gene or Chromosome Alterations - Pipeline Products by Territory

3.3 Inborn Gene or Chromosome Alterations - Pipeline Products by Regulatory Path

3.4 Inborn Gene or Chromosome Alterations - Pipeline Products by Estimated Approval Date

3.5 Inborn Gene or Chromosome Alterations - Ongoing Clinical Trials

4 Inborn Gene or Chromosome Alterations - Pipeline Products under Development by Companies

4.1 Inborn Gene or Chromosome Alterations Companies - Pipeline Products by Stage of Development

4.2 Inborn Gene or Chromosome Alterations - Pipeline Products by Stage of Development

5 Inborn Gene or Chromosome Alterations Companies and Product Overview

5.1 3D Signatures Inc Company Overview

5.2 Agena Bioscience, Inc Company Overview

5.3 Amarantus Bioscience Holdings Inc Company Overview

5.4 Ariosa Diagnostics Inc Company Overview

5.5 Atomic International Company Overview

5.6 AutoGenomics Inc Company Overview

5.7 Avellino Lab USA, Inc. Company Overview

5.8 Baylor College of Medicine Company Overview

5.9 BCML GmbH Company Overview

5.10 BioCeps (Inactive) Company Overview

5.11 Celula Inc Company Overview

5.12 Children's Hospital Boston Company Overview

5.13 Cincinnati Children's Hospital Medical Center Company Overview

5.14 Columbia University Company Overview

5.15 Da An Gene Co Ltd Company Overview

5.16 Deutsches Institut fur Ernahrungsforschung Company Overview

5.17 Epinex Diagnostics, Inc. Company Overview

5.18 Fina Biotech Company Overview

5.19 Firalis SAS Company Overview

5.20 Fluidigm Corp Company Overview

5.21 Fraunhofer-Gesellschaft zur Forderung der Angewandten Forschung eV Company Overview

5.22 Genekam Biotechnology AG Company Overview

5.23 Genentech Inc Company Overview

5.24 Genetic Analysis AS Company Overview

5.25 GENEWIZ Inc Company Overview

5.26 German Cancer Research Center Company Overview

5.27 GILUPI Nanomedizin Company Overview

5.28 Good Start Genetics Inc Company Overview

5.29 Goodgene Inc Company Overview

5.30 Hadassah Medical Center Company Overview

5.31 Helicos BioSciences Corporation Company Overview

5.32 Helmholtz Zentrum Munchen Deutsches Forschungszentrum fur Gesundheit und Umwelt (GmbH) Company Overview

5.33 Illumina, Inc. Company Overview

5.34 Immunexpress Pty Ltd Company Overview

5.35 Inform Genomics Inc Company Overview

5.36 Institute of Cancer Research Company Overview

5.37 Interleukin Genetics Inc Company Overview

5.38 John Hopkins University Company Overview

5.39 JS Genetics Inc Company Overview

5.40 Juneau Biosciences LLC Company Overview

5.41 KellBenx Inc Company Overview

5.42 Laboratory Corp of America Holdings Company Overview

5.43 Laval University Company Overview

5.44 Maastricht University Medical Center Company Overview

5.45 Massachusetts Eye and Ear Infirmary Company Overview

5.46 Max-Delbruck-Centrum fur Molekulare Medizin (MDC) Company Overview

5.47 Medical Research Council Company Overview

5.48 National Institute of Immunohaematology Company Overview

5.49 National University of Singapore Company Overview

5.50 NewGene Ltd Company Overview

5.51 Northwestern University Company Overview

5.52 NX PharmaGen Inc Company Overview

5.53 OncoGenesis Company Overview

5.54 Oxford Biodynamics Ltd Company Overview

5.55 Paragon Medical, Inc. Company Overview

5.56 PerkinElmer Inc Company Overview

5.57 Population Diagnostics Inc Company Overview

5.58 PreCyte, Inc. Company Overview

5.59 Premaitha Health Plc Company Overview

5.60 Prenetics Inc Company Overview

5.61 Qiagen NV Company Overview

5.62 Quest Diagnostics Inc Company Overview

5.63 R-Biopharm AG Company Overview

5.64 Sansure Biotech Inc Company Overview

5.65 Sapien Biosciences Company Overview

5.66 Sequenom Inc Company Overview

5.67 Sequoia Genetics Company Overview

5.68 Sheba Medical Center Company Overview

5.69 SkylineDx BV Company Overview

5.70 Spartan Bioscience Inc Company Overview

5.71 Strand Life Sciences Pvt Ltd Company Overview

5.72 The University of Utah Company Overview

5.73 Transgenomic Inc Company Overview

5.74 Transplant Genomics Inc. Company Overview

5.75 TrovaGene Inc Company Overview

5.76 Tufts Medical Center Company Overview

5.77 University Hospital of Cologne Company Overview

5.78 University of Colorado Company Overview

5.79 University of Texas Health Science Center at Houston Company Overview

5.80 VitaPath Genetics, Inc. Company Overview

5.81 Xiamen Zeesan Biotech Co.,Ltd Company Overview

6 Inborn Gene or Chromosome Alterations- Recent Developments

6.1 Dec 07, 2016: Illumina appoints senior vice president and CFO

6.2 Dec 07, 2016: Illumina Extends Management Team, Appoints Sam A. Samad as Senior Vice President and Chief Financial Officer

6.3 Dec 05, 2016: NxGen MDx announces the move of their Non-invasive Prenatal Test in-house

6.4 Dec 05, 2016: Good Start Genetics Enters into Marketing Agreement with Roche Diagnostics

6.5 Dec 02, 2016: GeneNews to Raise USD3 Million in Private Placement of 8% Debentures Due 2019

6.6 Dec 01, 2016: The Centers For Medicare And Medicaid Services Establishes 2017 Pricing For Aneuploidy And Microdeletion Testing

6.7 Nov 29, 2016: CombiMatrix’s Pre-Implantation Genetic Screening by Next Generation Sequencing Granted Conditional Approval from New York State Department of Health

6.8 Nov 29, 2016: SenzaGen awarded EU grant of € 2,4 million in heavy competition, to develop GARDair for industry use

6.9 Nov 21, 2016: Premaitha establishes first service laboratory customer in Asia

6.10 Nov 17, 2016: genedrive Announces CE-IVD Certification for Genedrive Human Genotyping Test

6.11 Nov 15, 2016: Interleukin Genetics Reports Third Quarter 2016 Financial Results

6.12 Nov 14, 2016: Prospective clinical follow-up study with over 2,200 patients confirms high test accuracy of PrenaTest for fetal trisomies

6.13 Nov 11, 2016: GeneNews Announces Q3-2016 Financial Results and Provides Corporate Update

6.14 Nov 10, 2016: Avellino Labs to Introduce Keratoconus Screening Test in early 2017

6.15 Nov 09, 2016: Trovagene Reports Third Quarter 2016 Financial Results and Accomplishments

6.16 Nov 09, 2016: Natera Reports Third Quarter 2016 Financial Results

6.17 Nov 09, 2016: Daniel B. Polley, Ph.D., appointed Director of Lauer Tinnitus Research Center at Mass. Eye and Ear

6.18 Nov 03, 2016: GenMark Diagnostics Reports Q3 Financial Results

6.19 Nov 03, 2016: Fluidigm Announces Third Quarter Financial Results

6.20 Nov 02, 2016: CombiMatrix Reports Third Quarter 2016 Financial and Operating Results

6.21 Nov 02, 2016: QIAGEN Reports Results for Third Quarter and First Nine Months of 2016

6.22 Nov 02, 2016: Hologic Announces Financial Results for Fourth Quarter of Fiscal 2016

6.23 Nov 02, 2016: QIAGEN launches restructuring initiatives, revises outlook for 2016 earnings and provides initial net sales and adjusted earnings guidance for 2017

6.24 Nov 01, 2016: Illumina Reports Full Financial Results for Third Quarter of Fiscal Year 2016

6.25 Nov 01, 2016: Myriad Genetics Reports Fiscal First-Quarter 2017 Financial Results

6.26 Nov 01, 2016: Asuragen Launches QuantideX NGS RNA Lung Cancer Kit

6.27 Oct 31, 2016: NHS to adopt NIPT for high risk women

6.28 Oct 31, 2016: Luminex Reports Third Quarter 2016 Results; Raises Full Year Guidance

6.29 Oct 27, 2016: Thermo Fisher Scientific Reports Third Quarter 2016 Results

6.30 Oct 26, 2016: Laboratory Corporation of America Holdings Announces 2016 Third Quarter Results and Updates 2016 Guidance

6.31 Oct 25, 2016: Oxford BioDynamics presents results of study into epigenetic biomarkers for ALS at The Lancet Neurology Conference

6.32 Oct 24, 2016: German Court Issues Preliminary Injunction Against amedes Fetalis Test for Infringement of Non-Invasive Prenatal Screening Patent

6.33 Oct 24, 2016: ORYZON Reports Financial Results and Corporate Update for the 3rd Quarter Ended September 30, 2016

6.34 Oct 24, 2016: Analysis of rare circulating fetal cells make possible a new type of noninvasive genetic prenatal testing

6.35 Oct 20, 2016: Quest Diagnostics Reports Third Quarter 2016 Financial Results

6.36 Oct 19, 2016: RainDance Technologies Showcases the Power and Precision of Its Picodroplet Platform at ASHG 2016 Annual Meeting

6.37 Oct 19, 2016: Lineagen Announces Presentation at Annual Meeting of the American Society of Human Genetics and Commercial Launch of a Proprietary Variant Index

6.38 Oct 19, 2016: Fluidigm Names S. Christopher Linthwaite as New Chief Executive Officer

6.39 Oct 17, 2016: Reprogenetics, Recombine, and Genesis Genetics Unite As Part of the CooperSurgical Family at ASRM 2016 Scientific Congress

6.40 Oct 14, 2016: IntegraGen Reports Revenues for First Half of 2016

6.41 Oct 13, 2016: Natera Announces Poster Presentation on Horizon carrier screen at the 2016 American Society for Reproductive Medicine (ASRM) Conference

6.42 Oct 13, 2016: Natera Announces Poster Presentation on Spectrum pre-implantation genetic test at the 2016 American Society for Reproductive Medicine (ASRM) Conference

6.43 Oct 12, 2016: Fluidigm Announces Preliminary Third Quarter 2016 Revenue

6.44 Oct 10, 2016: Illumina Announces Preliminary Revenue for Third Quarter of Fiscal Year 2016

7 Appendix

7.1 Methodology

7.2 About

1.1 List of Tables

Table 1: Inborn Gene or Chromosome Alterations - Pipeline Products by Stage of Development

Table 2: Inborn Gene or Chromosome Alterations - Pipeline Products by Territory

Table 3: Inborn Gene or Chromosome Alterations - Pipeline Products by Regulatory Path

Table 4: Inborn Gene or Chromosome Alterations - Pipeline Products by Estimated Approval Date

Table 5: Inborn Gene or Chromosome Alterations - Ongoing Clinical Trials

Table 6: Inborn Gene or Chromosome Alterations Companies - Pipeline Products by Stage of Development

Table 7: Inborn Gene or Chromosome Alterations - Pipeline Products by Stage of Development

Table 8: 3D Signatures Inc Pipeline Products & Ongoing Clinical Trials Overview

Table 9: 3D Telo-AD Test - Product Status

Table 10: 3D Telo-AD Test - Product Description

Table 11: Agena Bioscience, Inc Pipeline Products & Ongoing Clinical Trials Overview

Table 12: Sensigene Trisomy 21 Laboratory Developed Test - Product Status

Table 13: Sensigene Trisomy 21 Laboratory Developed Test - Product Description

Table 14: Amarantus Bioscience Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview

Table 15: Diagnostic Test - IFN-Beta Resistance - Product Status

Table 16: Diagnostic Test - IFN-Beta Resistance - Product Description

Table 17: Ariosa Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview

Table 18: Harmony Prenatal Test - Product Status

Table 19: Harmony Prenatal Test - Product Description

Table 20: Atomic International Pipeline Products & Ongoing Clinical Trials Overview

Table 21: Thrombophilia Genotyping Assay - Product Status

Table 22: Thrombophilia Genotyping Assay - Product Description

Table 23: AutoGenomics Inc Pipeline Products & Ongoing Clinical Trials Overview

Table 24: DNA Guided Diagnostic Test - Cardiovascular Disease - Product Status

Table 25: DNA Guided Diagnostic Test - Cardiovascular Disease - Product Description

Table 26: DNA Guided Diagnostic Test - Diabetes - Product Status

Table 27: DNA Guided Diagnostic Test - Diabetes - Product Description

Table 28: DNA Guided Diagnostic Test - Obesity - Product Status

Table 29: DNA Guided Diagnostic Test - Obesity - Product Description

Table 30: INFINITI CFTR-31 Assay - Product Status

Table 31: INFINITI CFTR-31 Assay - Product Description

Table 32: INFINITI Factor II-V And MTHFR Assay - Product Status

Table 33: INFINITI Factor II-V And MTHFR Assay - Product Description

Table 34: INFINITI FMF Assay - Product Status

Table 35: INFINITI FMF Assay - Product Description

Table 36: INFINITI MTHFR Assay - Product Status

Table 37: INFINITI MTHFR Assay - Product Description

Table 38: INFINITI SMART - Factor II - Product Status

Table 39: INFINITI SMART - Factor II - Product Description

Table 40: INFINITI SMART - Factor V - Product Status

Table 41: INFINITI SMART - Factor V - Product Description

Table 42: INFINITI SMART - MTHFR - Product Status

Table 43: INFINITI SMART - MTHFR - Product Description

Table 44: INFINITI System Assay For Factor II - Product Status

Table 45: INFINITI System Assay For Factor II - Product Description

Table 46: INFINITI System Assay For Factor II-V Leiden - Product Status

Table 47: INFINITI System Assay For Factor II-V Leiden - Product Description

Table 48: INFINITI System Assay For Factor V Leiden - Product Status

Table 49: INFINITI System Assay For Factor V Leiden - Product Description

Table 50: Avellino Lab USA, Inc. Pipeline Products & Ongoing Clinical Trials Overview

Table 51: Keratoconus Screening Test - Product Status

Table 52: Keratoconus Screening Test - Product Description

Table 53: Baylor College of Medicine Pipeline Products & Ongoing Clinical Trials Overview

Table 54: Diagnostic Assay - Rett Syndrome - Product Status

Table 55: Diagnostic Assay - Rett Syndrome - Product Description

Table 56: BCML GmbH Pipeline Products & Ongoing Clinical Trials Overview

Table 57: Prenatal Diagnosis Biochip - Product Status

Table 58: Prenatal Diagnosis Biochip - Product Description

Table 59: BioCeps (Inactive) Pipeline Products & Ongoing Clinical Trials Overview

Table 60: Prenatal Diagnostic Test - Product Status

Table 61: Prenatal Diagnostic Test - Product Description

Table 62: Celula Inc Pipeline Products & Ongoing Clinical Trials Overview

Table 63: Non-Invasive Pre-Natal Test - Product Status

Table 64: Non-Invasive Pre-Natal Test - Product Description

Table 65: Children's Hospital Boston Pipeline Products & Ongoing Clinical Trials Overview

Table 66: Diagnostic Assay - Cystic Fibrosis - Product Status

Table 67: Diagnostic Assay - Cystic Fibrosis - Product Description

Table 68: Diagnostic Assay - Developmental Delay - Product Status

Table 69: Diagnostic Assay - Developmental Delay - Product Description

Table 70: Cincinnati Children's Hospital Medical Center Pipeline Products & Ongoing Clinical Trials Overview

Table 71: Diagnostic Assay - Asthma - Product Status

Table 72: Diagnostic Assay - Asthma - Product Description

Table 73: Diagnostic Assay - Crohn’s Disease - Product Status

Table 74: Diagnostic Assay - Crohn’s Disease - Product Description

Table 75: Diagnostic Biomarker - Biliary Atresia - Product Status

Table 76: Diagnostic Biomarker - Biliary Atresia - Product Description

Table 77: Fetal Maturity Assessment Test - Product Status

Table 78: Fetal Maturity Assessment Test - Product Description

Table 79: Gene Chip Based Diagnostic Test - Liver Diseases - Product Status

Table 80: Gene Chip Based Diagnostic Test - Liver Diseases - Product Description

Table 81: Genetic Marker Diagnostic Test - Food Allergy - Product Status

Table 82: Genetic Marker Diagnostic Test - Food Allergy - Product Description

Table 83: Columbia University Pipeline Products & Ongoing Clinical Trials Overview

Table 84: Biomarker-Based Diagnostic Test - Autism - Product Status

Table 85: Biomarker-Based Diagnostic Test - Autism - Product Description

Table 86: Diagnostic Biomarker Test - Schizophrenia - Product Status

Table 87: Diagnostic Biomarker Test - Schizophrenia - Product Description

Table 88: Da An Gene Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

Table 89: Real Time PCR Kit - Alpha-Mediterranean Anaemia - Product Status

Table 90: Real Time PCR Kit - Alpha-Mediterranean Anaemia - Product Description

Table 91: Real Time PCR Kit - Beta-Mediterranean Anaemia - Product Status

Table 92: Real Time PCR Kit - Beta-Mediterranean Anaemia - Product Description

Table 93: Deutsches Institut fur Ernahrungsforschung Pipeline Products & Ongoing Clinical Trials Overview

Table 94: Diagnostic Test - Obesity Associated Diabetes - Product Status

Table 95: Diagnostic Test - Obesity Associated Diabetes - Product Description

Table 96: Epinex Diagnostics, Inc. Pipeline Products & Ongoing Clinical Trials Overview

Table 97: Down Syndrome Screen Test - Product Status

Table 98: Down Syndrome Screen Test - Product Description

Table 99: Fina Biotech Pipeline Products & Ongoing Clinical Trials Overview

Table 100: Dx Restenosis - Product Status

Table 101: Dx Restenosis - Product Description

Table 102: Firalis SAS Pipeline Products & Ongoing Clinical Trials Overview

Table 103: Prognostic miRNA Assay - Heart Failure - Product Status

Table 104: Prognostic miRNA Assay - Heart Failure - Product Description

Table 105: Fluidigm Corp Pipeline Products & Ongoing Clinical Trials Overview

Table 106: Non-Invasive Prenatal Diagnostic Test - Fetal Aneuploidies - Product Status

Table 107: Non-Invasive Prenatal Diagnostic Test - Fetal Aneuploidies - Product Description

Table 108: Fraunhofer-Gesellschaft zur Forderung der Angewandten Forschung eV Pipeline Products & Ongoing Clinical Trials Overview

Table 109: Biomarker Based Diagnostic Assay - COPD - Product Status

Table 110: Biomarker Based Diagnostic Assay - COPD - Product Description

Table 111: Genekam Biotechnology AG Pipeline Products & Ongoing Clinical Trials Overview

Table 112: Rotavirus Genotyping PCR Kit - Product Status

Table 113: Rotavirus Genotyping PCR Kit - Product Description

Table 114: Genentech Inc Pipeline Products & Ongoing Clinical Trials Overview

Table 115: Arbaclofen Companion Diagnostic Assay - Product Status

Table 116: Arbaclofen Companion Diagnostic Assay - Product Description

Table 117: Genetic Analysis AS Pipeline Products & Ongoing Clinical Trials Overview

Table 118: GA-map Diabetes II - Product Status

Table 119: GA-map Diabetes II - Product Description

Table 120: GA-map Obesity - Product Status

Table 121: GA-map Obesity - Product Description

Table 122: GENEWIZ Inc Pipeline Products & Ongoing Clinical Trials Overview

Table 123: Diagnostic Panel - Gut Microbiomes - Product Status

Table 124: Diagnostic Panel - Gut Microbiomes - Product Description

1.2 List of Figures

Figure 1: Inborn Gene or Chromosome Alterations - Pipeline Products by Stage of Development

Figure 2: Inborn Gene or Chromosome Alterations - Pipeline Products by Territory

Figure 3: Inborn Gene or Chromosome Alterations - Pipeline Products by Regulatory Path

Figure 4: Inborn Gene or Chromosome Alterations - Pipeline Products by Estimated Approval Date

Figure 5: Inborn Gene or Chromosome Alterations - Ongoing Clinical Trials
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • 3D Signatures Inc
  • Agena Bioscience, Inc
  • Amarantus Bioscience Holdings Inc
  • Ariosa Diagnostics Inc
  • Atomic International
  • AutoGenomics Inc
  • Avellino Lab USA, Inc.
  • Baylor College of Medicine
  • BCML GmbH
  • BioCeps
  • Celula Inc
  • Children's Hospital Boston
  • Cincinnati Children's Hospital Medical Center
  • Columbia University
  • Da An Gene Co Ltd
  • Deutsches Institut fur Ernahrungsforschung
  • Epinex Diagnostics, Inc.
  • Fina Biotech
  • Firalis SAS
  • Fluidigm Corp
  • Fraunhofer-Gesellschaft zur Forderung der Angewandten Forschung eV
  • Genekam Biotechnology AG
  • Genentech Inc
  • Genetic Analysis AS
  • GENEWIZ Inc
  • German Cancer Research Center
  • GILUPI Nanomedizin
  • Good Start Genetics Inc
  • Goodgene Inc
  • Hadassah Medical Center
  • Helicos BioSciences Corporation
  • Helmholtz Zentrum Munchen Deutsches Forschungszentrum fur Gesundheit und Umwelt (GmbH)
  • Illumina, Inc.
  • Immunexpress Pty Ltd
  • Inform Genomics Inc
  • Institute of Cancer Research
  • Interleukin Genetics Inc
  • John Hopkins University
  • JS Genetics Inc
  • Juneau Biosciences LLC
  • KellBenx Inc
  • Laboratory Corp of America Holdings
  • Laval University
  • Maastricht University Medical Center
  • Massachusetts Eye and Ear Infirmary
  • Max-Delbruck-Centrum fur Molekulare Medizin (MDC)
  • Medical Research Council
  • National Institute of Immunohaematology
  • National University of Singapore
  • NewGene Ltd
  • Northwestern University
  • NX PharmaGen Inc
  • OncoGenesis
  • Oxford Biodynamics Ltd
  • Paragon Medical, Inc.
  • PerkinElmer Inc
  • Population Diagnostics Inc
  • PreCyte, Inc.
  • Premaitha Health Plc
  • Prenetics Inc
  • Qiagen NV
  • Quest Diagnostics Inc
  • R-Biopharm AG
  • Sansure Biotech Inc
  • Sapien Biosciences
  • Sequenom Inc
  • Sequoia Genetics
  • Sheba Medical Center
  • SkylineDx BV
  • Spartan Bioscience Inc
  • Strand Life Sciences Pvt Ltd
  • The University of Utah
  • Transgenomic Inc
  • Transplant Genomics Inc.
  • TrovaGene Inc
  • Tufts Medical Center
  • University Hospital of Cologne
  • University of Colorado
  • University of Texas Health Science Center at Houston
  • VitaPath Genetics, Inc.
  • Xiamen Zeesan Biotech Co.,Ltd
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll